Effect Of Chronobıologıcal Nutrıtıon On Premature Babıes

Sponsor
Eskisehir Osmangazi University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05849948
Collaborator
(none)
94
2
12

Study Details

Study Description

Brief Summary

The aim of this study is to determine the effect of chronobiological nutrition approach on the growth and breastfeeding processes of premature babies. It will be carried out in a randomized controlled experimental design. In the study, it is planned to have 2 groups as experimental and control. As a result of the power analysis using the G Power 3.0.10 program, 90% power; A total of at least 78 samples were found to be sufficient in the study with a 5% margin of error (n1: 39; n2: 39). However, considering that the case could be lost, it was decided to increase it by 20% to 94 babies. Infants will be assigned to groups using a stratified sequential block randomization method. Premature babies will be stratified by week of gestation, birth weight and sex, and then an equal number of babies will be assigned to each group by blocking.

The appointment of premature infants will be decided by sequential block randomization.

After the descriptive information of the babies assigned to the groups is recorded in the questionnaire, the experimental group will be fed by applying the chronobiological nutrition approach. The control group will be fed without applying the chronobiological nutrition approach. The discharge times will be calculated for both groups.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: choronobiological nutrition
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
94 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Health Services Research
Official Title:
The Effect of Chronobiological Nutritional Approach on Growth and Breastfeeding Processes of Premature Babies
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: choronobiological nutrition group

newborns were fed according to chronobiological nutrition

Behavioral: choronobiological nutrition
Providing infant nutrition in accordance with crinobiological nutrition

No Intervention: control group

newborns will be fed in the order in which breastmilk is delivered to the hospital

Outcome Measures

Primary Outcome Measures

  1. The change in the discharge time of newborns will be evaluated by using a questionnaire prepared by the researcher. [The newborn will be evaluated once a week for up to an average of 6 weeks after the date of hospitalization.]

    newborn was evaluated during hospital treatment

Secondary Outcome Measures

  1. Weight gain of newborns will be evaluated using a questionnaire prepared by the investigator. [The newborn will be evaluated once a week for up to an average of 6 weeks after the date of hospitalization.]

    newborn was evaluated during hospital treatment

Other Outcome Measures

  1. Height growth of newborns will be evaluated using a questionnaire prepared by the researcher. [The newborn will be evaluated once a week for up to an average of 6 weeks after the date of hospitalization.]

    newborn was evaluated during hospital treatment

  2. Head circumference of newborns will be evaluated using a questionnaire prepared by the researcher. [The newborn will be evaluated once a week for up to an average of 6 weeks after the date of hospitalization.]

    newborn was evaluated during hospital treatment

  3. The duration of breastfeeding of newborns by their mothers will be evaluated using a questionnaire prepared by the researcher. [will be evaluated once a month for 6 months after discharge]

    The newborn was evaluated in the first 6 months after discharge.

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Weeks to 36 Weeks
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Being treated in the NICU

  • Gestation week is between 30 and 36

  • The delivery took place in the hospital where the study was conducted.

  • 70% of the daily enteral feeding is done with breast milk

Exclusion Criteria:
  • The baby is less than 30 weeks of gestation and greater than 36 weeks of gestation.

  • Having neurological sequelae

  • Having Grade 4 intraventricular bleeding

  • The development of problems such as sepsis, NEC, which may change the general condition

  • Being followed in invasive mechanical ventilation

  • Receiving narcotic analgesics and sedation

  • The baby has been shipped from outside

  • Having undergone gastrointestinal (GIS) surgery or having GIS anomaly

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Eskisehir Osmangazi University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ezgi Ayvaz, NURSE, Eskisehir Osmangazi University
ClinicalTrials.gov Identifier:
NCT05849948
Other Study ID Numbers:
  • YENİDOĞAN DOKTORA TEZ
First Posted:
May 9, 2023
Last Update Posted:
May 9, 2023
Last Verified:
Apr 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ezgi Ayvaz, NURSE, Eskisehir Osmangazi University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 9, 2023